Not Yet Recruiting
Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a, for Advanced Pancreatic Ductal Adenocarcinoma
NCT07619521
- Conditions
- Advanced Pancreatic Ductal Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +10 more
- Locations
-
Not specified